CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Price to Book Value: 12.76 for March 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 25, 2024 | 12.76 |
| March 22, 2024 | 12.76 |
| March 21, 2024 | 12.76 |
| March 20, 2024 | 12.75 |
| March 19, 2024 | 12.76 |
| March 18, 2024 | 12.75 |
| March 15, 2024 | 12.74 |
| March 14, 2024 | 12.75 |
| March 13, 2024 | 12.74 |
| March 12, 2024 | 12.74 |
| March 11, 2024 | 12.74 |
| March 08, 2024 | 12.69 |
| March 07, 2024 | 12.69 |
| March 06, 2024 | 12.68 |
| March 05, 2024 | 12.66 |
| March 04, 2024 | 12.64 |
| March 01, 2024 | 12.66 |
| February 29, 2024 | 12.64 |
| February 28, 2024 | 12.67 |
| February 27, 2024 | 12.69 |
| February 26, 2024 | 12.68 |
| February 23, 2024 | 12.66 |
| February 22, 2024 | 12.63 |
| February 21, 2024 | 12.64 |
| February 20, 2024 | 12.65 |
| Date | Value |
|---|---|
| February 16, 2024 | 12.64 |
| February 15, 2024 | 12.65 |
| February 14, 2024 | 12.64 |
| February 13, 2024 | 12.62 |
| February 12, 2024 | 12.65 |
| February 09, 2024 | 10.09 |
| February 08, 2024 | 9.798 |
| February 07, 2024 | 9.421 |
| February 06, 2024 | 9.519 |
| February 05, 2024 | 9.366 |
| February 02, 2024 | 9.350 |
| February 01, 2024 | 9.574 |
| January 31, 2024 | 9.229 |
| January 30, 2024 | 9.214 |
| January 29, 2024 | 9.249 |
| January 26, 2024 | 8.973 |
| January 25, 2024 | 8.751 |
| January 24, 2024 | 8.902 |
| January 23, 2024 | 9.078 |
| January 22, 2024 | 9.347 |
| January 19, 2024 | 9.545 |
| January 18, 2024 | 9.261 |
| January 17, 2024 | 9.354 |
| January 16, 2024 | 9.440 |
| January 12, 2024 | 9.257 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4298
Minimum
Nov 25 2019
25.81
Maximum
Mar 17 2023
4.786
Average
2.796
Median
Jul 02 2021
Price to Book Value Benchmarks
| Gilead Sciences Inc | 4.654 |
| Assure Holdings Corp | -- |
| Societal CDMO Inc (DELISTED) | 1.982 |
| AN2 Therapeutics Inc | 0.6124 |
| Madrigal Pharmaceuticals Inc | 11.60 |
Price to Book Value Related Metrics
| Price | 32.48 |
| Earnings Yield | -3.05% |